首页> 美国政府科技报告 >Limitations of the Fluorescent Probe Viability Assay
【24h】

Limitations of the Fluorescent Probe Viability Assay

机译:荧光探针活力测定的局限性

获取原文

摘要

Cell viability commonly is determined flow cytometrically by the carboxyfluorescein diacetate (CFDA)/propidium iodide (PI) assay. CFDA is taken up by the viable cell and converted via cytoplasmic esterase-catalyzed hydrolysis to carboxyfluorescein (CF). CF fluorescence intensity is considered to be an index of cellular vigor. It is generally accepted that the viable cell excludes PI. PI uptake is indicative of irreversible cellular injury and presages cell death. The authors observe that, following incubation for 4 hr with 0.5 - 1.0 microMolar tributyltin (TBT), murine erythroleukemic cells (MELC) exhibit supranormal CF fluorescence and exclude PI. Apparent cell volume is unaltered. However, the rate of growth (cell duplication) of these cells is depressed, suggesting that supranormal CF fluorescence, even in the absence of PI uptake, is indicative of cellular perturbation. Furthermore, at higher TBT concentrations (>1.0,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号